Ann C. Tunstall

Biography

 Ann has worked as a regulatory and clinical professional in the healthcare industry for more than 25 years, identifying and implementing effective regulatory and clinical development strategies for novel and repositioned pharmaceuticals and combination products. Her experience covers a wide range of therapeutic areas, with a focus on neurological indications. She started her career as a research and development scientist. After several years she moved into regulatory and clinical consulting, and worked for a number of Washington, DC-based healthcare consulting companies, most recently for SciLucent LLC. In this role she has routinely prepared successful pre-IND, IND and marketing applications to the U.S. Food and Drug Administration and other regulatory authorities, as well as clinical protocols, study reports, and other regulatory and study-related documents. She has assisted companies in directing and managing clinical trial programs from initial Phase 1 through pivotal Phase 3 trials. Ann has also served as the director of a Midwest clinical research institute and Director of Clinical Development for a healthcare start-up. Ann has a Ph.D. in Biomedical Engineering from the University of Texas Southwestern Medical Center, an M.S. in Material Science from Duke University, and a B.S. in Biomedical Engineering from Duke University

Research Interest

 Biomedical Engineering